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Footnote1: The genetic nomenclature used in this manuscript follows the guidelines of 
the Zebrafish Nomenclature Committee (ZNC) for fish genes and proteins and the 
HUGO Gene Nomenclature committee for mammalian genes and proteins. 
 
Footnote2:  5α-reductase gene (srd5a), 11β-hydroxytestosterone (OHT), 11β-
hydroxysteroid dehydrogenase gene (hsd11b), 11-ketotestosterone (11KT), 17β-
estradiol (E2), aromatase gene (cyp19a1a), body mass (bm), cholesterol side chain 
cleavage cytochrome P450 gene (cyp11a1), 5α-dihydrotestosterone (DHT), dimethyl 
sulfoxide (DMSO), finasteride (FIN), intraperitoneally (ip), phosphate buffer saline 
(PBS), reproductive cycles (RCs), ribosomal protein S18 gene (rps18), steroid 11-β-
hydroxylase gene (cyp11b1), testosterone (T).  
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Abstract 
In teleosts, spermatogenesis is regulated by pituitary gonadotropins and sex 
steroids. 5α-dihydrotestosterone (DHT), derived from testosterone (T) through the 
action of 5α-reductase, has recently been suggested to play a physiologically important 
role in some fish species. In this study, gilthead seabream, Sparus aurata L., males 
received an implant of 1 µg T/g body mass (bm) or vehicle alone and, 7 days later, 1 mg 
finasteride (FIN, an inhibitor of 5α-reductase)/kg bm or vehicle. Serum levels of T, 11-
ketotestosterone (11KT), DHT and 17β-estradiol (E2), and the mRNA levels of the 
main enzymes involved in their synthesis, were analysed. T promoted a transient 
increase in the serum levels of T, 11KT and E2 but a decrease in those of DHT at day 
15 following T injection, in accordance with the up-regulation of mRNA levels of the 
enzymes involved in T transformation to 11KT (coding genes: cyp11b1 and hsd11b) 
and the down-regulation of mRNA levels of the enzyme responsible for T 
transformation to DHT (coding gene: srd5a). Interestingly, a similar effect was 
observed when FIN was injected. However, when fish were injected with T and FIN 
successively (T+FIN), control levels were not recovered at the end of the experimental 
period (28 days). DHT seems to regulate E2 serum levels via the down-regulation of 
mRNA levels of aromatase (coding gene: cyp19a1a), which is needed for the 
transformation of T into E2. The testis histology, together with the proliferative rates 
recorded upon T, FIN or T+FIN treatment, suggests that DHT is involved in the onset 
of the meiotic phase of spermatogenesis.  
 
 
Keywords: 5α-reductase, sex steroids, steroidogenic enzyme inhibitors, Sparus aurata. 
 
4  
1. Introduction 
Androgens play an important role in controlling sexual differentiation and 
spermatogenesis in males. Testosterone (T) serves as precursor of other sex steroids -  
both androgens [1,2] and estrogens [3]. Although 5α-dihydrotestosterone (DHT) has 
been considered the most potent androgen in mammals, birds, reptiles and amphibians 
[4–6], T and 11-ketotestosterone (11KT) are generally considered to be the major 
androgens in fish [1]. However, significant serum levels of DHT have recently been 
detected in some fish species and its androgenic effect has been reported following its 
inclusion in the diet or in flow-through systems [2,7–9]. The main organ that 
synthesizes biologically active steroids is the gonad, in a process whereby the regulation 
of the amounts of the specific mRNAs coding for steroidogenic enzymes controls the 
activity levels of these enzymes [10,11]. The first step in steroid synthesis is catalyzed 
by the cholesterol side chain cleavage cytochrome p450 (coding gene: cyp11a1) [10]. 
This reaction is the first rate-limiting and hormonally regulated step in the synthesis of 
all steroids [12]. Subsequently, T is transformed into 11KT in a two-step process: the 
hydroxylation of T to 11β-hydroxytestosterone (OHT) by the enzyme 11β-hydroxylase 
(coding gene: cyp11b1), followed by its conversion into 11KT via 11β-hydroxysteroid 
dehydrogenase (coding gene: hsd11b) [13–15], or into DHT by 5α-reductase activity 
(coding gene: srd5a) [13]. Moreover, T is transformed into 17β-estradiol (E2) by 
aromatase activity (coding gene: cyp19a1a) [10]. Few studies have focused on the 
disruptive effects of inhibitors of the 5α-reductase activity used in human 
pharmacological treatments, such as dutasteride [16] and finasteride (FIN) [17], on the 
reproduction of fish. The results obtained indicate that these treatments affect the 
reproductive process. In fact, the changes observed suggest that 5α-reductase could be 
involved in steroid biosynthesis and play a role in androgen signaling via DHT in fish 
[16,17]. On the other hand, it has been reported that FIN produces feminization in rats 
[18] and may lead to the development of abnormalities in rhesus monkeys [6]. As 
regards amphibians, FIN produced severe disruption of spermatogenesis and reduced 
proliferation activity in Xenopus laevis [19], and dutasteride accelerated ovarian 
differentiation in female tadpoles of Bufo bufo and Rana dalmatina [20,21].  
The gilthead seabream (Sparus aurata L.) is a protandrous teleost fish that has a 
bisexual gonad with two coexisting areas: the testicular area which develops during the 
first two reproductive cycles (RCs) and the ovarian area which is not functional during 
this time. As regard the development of the testicular area, four stages have been 
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defined in the first RC: spermatogenesis, spawning, post-spawning and resting [22,23]. 
In this species, exogenous T treatment was seen not to affect the first step of steroid 
synthesis but enhanced the transcript levels coding for the enzymes involved in the 
transformation of T into DHT and E2 [24].   
These observations prompted us to experimentally inhibit the 5α-reductase 
activity using FIN in gilthead seabream males in order to elucidate the importance of 
DHT in the reproductive physiology of this hermaphrodite fish. The relationship 
between the different sex steroid levels and between them and the transcript levels 
coding for the steroidogenic enzymes was also analysed. A morphological study was 
made of the testicular area, including an assessment of proliferating cells with an anti-
PCNA serum and the calculation of proliferative rates in the different experimental 
groups established.  
2. Material and methods 
2.1. Animals and experimental design 
Gilthead seabream (Sparus aurata L.) (Actinopterygii, Perciformes, Sparidae) 
males of 169.15 ± 17.72 g mean body mass (bm) were bred and kept at the Centro 
Oceanográfico de Murcia (IEO, Mazarrón, Murcia). The fish were kept in 2 m3 tanks 
with the water temperature ranging from 23.2 to 25.8 ºC, a flow-through circuit, an 
aeration and filtration system and a natural photoperiod. The environmental parameters, 
mortality and food intake were recorded daily. The experiment was performed in July, 
when the fish were in the resting stage of the first RC [22]. The fish were fed three 
times a day ad libitum and were ip injected with 5 µl slow-release coconut oil g-1 bm as 
vehicle or the same containing 1 µg T g-1 bm (n = 30 fish/group), a dose previously 
shown to promote supraphysiological T serum levels [24,25]. After 7 days, both groups 
were divided again and 15 fish were ip injected with 1 ml of phosphate buffer saline 
(PBS) with 0.1 % of dimethyl sulfoxide (DMSO) as vehicle and 15 fish were ip injected 
with PBS-DMSO containing 1 µg FIN g-1 bm, a dose that we estimated would inhibit 
5α-reductase activity. Thus, four experimental groups were established: i) a control 
group consisting of fish injected with coconut oil and PBS, ii) T treated group 
consisting of fish injected with a T-implant and PBS, iii) FIN treated group consisting 
of fish injected with coconut oil and FIN, and iv) T+FIN treated group consisting of fish 
injected with a T-implant and FIN (Fig. 1). The fish were fasted for 24 h before 
sampling 7, 15 and 21 days after FIN injection (14, 21 and 28 days after T injection, 
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respectively). At each sampling time four fish per group were tranquilized by 20 µl L-1 
of clove oil and, immediately, anesthetized with 40 µl L-1 of clove oil. Blood was 
obtained from the caudal peduncle and the serum samples were obtained by 
centrifugation (10,000 xg, 1 min, 4 ºC) and immediately frozen in liquid nitrogen and 
stored at - 80 ºC until use. Then, fish were weighed, decapitated and the gonads were 
removed and processed for mRNA analysis and light microscopy and 
immunocytochemistry as described below.  
 The experiments described comply with the Guidelines of the European Union 
Council (2010/63/EU) and Spanish directive RD53/2013. All specimens studied were 
handled in accordance with the Guidelines of the Bioethical Committee of the IEO 
(reference REGA ES300261040017) and the Bioethical Committee of the University of 
Murcia (reference REGA ES300305440012). 
2.2. Analytical techniques 
Serum (n=4 fish/sampling time and group) levels of T, 11KT and E2 were 
quantified by ELISA following the method previously described [26]. Steroids were 
extracted from 10 μl of serum in 1.3 ml of methanol (Panreac). Then, the methanol was 
evaporated at 37 ºC and the steroids were resuspended in 400 μl of reaction buffer [0.1 
M phosphate buffer with 1 mM EDTA (Sigma), 0.4 M NaCl (Sigma), 1.5 mM NaN3 
(Sigma) and 0.1 % albumin from bovine serum (Sigma)]. Aliquots of these solutions 
(50 μl) were dispensed into microtiter plate wells (MaxiSorp; Nunc) so that 1.25 μl of 
serum were used in each well for all the assays. T, 11KT and E2 standards, mouse anti-
rabbit IgG monoclonal antibody, specific anti-steroid antibodies and enzymatic tracers 
(steroid acetylcholinesterase conjugates) were obtained from Cayman Chemical. A 
standard curve from 6.13 x 10-4 to 5 ng ml-1 (0.03-250 pg well-1), a blank and a non-
specific binding control (negative control) were established for all the assays. Standards 
and extracted serum samples were run in duplicate and all the measurements were 
corrected with the blank and negative control. The lower limit of detection for all the 
assays was 12.21 pg ml-1. The intra-assay coefficients of variation (calculated from 
sample duplicates) were 9.24 ± 1.45 % for T, 7.36 ± 1.15 % for 11KT and 15.74 ± 2.19 
% for E2 assays. The inter-assay coefficients of variation were 4.08 ± 0.09 % for T, 7.18 
± 0.32 % for 11KT and 3.02 ± 0.07 % for E2 assays. Details on cross-reactivity for 
specific antibodies were provided by the supplier (0.01 % of anti-11KT reacts with T; 
2.2 % of anti-T reacts with 11KT; and 0.1 % of anti-E2 reacts with T). Serum (n=4 
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fish/sampling time and group) levels of DHT were quantified using the 5α-
dihydrotestosterone ELISA kit (DRG diagnostics) following the manufacturer’s 
instructions. Details on cross-reactivity for the specific antibody were provided by the 
supplier (8.7 % of anti-DHT reacts with T).  
2.3. Analysis of mRNA levels 
Total RNA was extracted from the gonad (n=4 fish/sampling time and group) 
with TRIzol reagent (Cayman) following the manufacturer’s instructions. RNA was 
treated with RQ1 RNAse-free DNAse, amplification grade (1 unit µg-1 RNA, Promega). 
BioScript Reverse Transcriptase (Bioline) was used to synthesize first strand cDNA 
with oligo-dT18 primer from 1 µg of total RNA, at 42 ºC for 60 min. 
Transcript levels of the genes coding for steroidogenesis-related molecules - the 
cholesterol side chain cleavage cytochrome P450 (cyp11a1), steroid 11-β-hydroxylase 
(cyp11b1), 11β-hydroxysteroid dehydrogenase (hsd11b), 5α-reductase (srd5a) and 
aromatase (cyp19a1a) - were analysed by real-time PCR performed with an ABI 
PRISM 7500 instrument (Applied Biosystems) using SYBR Green PCR Core Reagents 
(Applied Biosystems) as previously described [27]. For each mRNA, gene expression 
was corrected by the ribosomal protein S18 gene expression (rsp18) content in each 
sample. The gilthead seabream specific primers used are shown in Table 1. Less than 2 
% variation in rsp18 gene expression was observed between samples.  
2.4. Light microcopy and immunocytochemistry 
Gonad fragments (n = 4 fish/group and time) were fixed in Bouin’s solution for 
16 h at 4 °C, embedded in paraffin (Paraplast Plus; Sherwood Medical) and sectioned at 
5 μm. After dewaxing and rehydration, some sections were stained with haematoxylin–
eosin in order to determine the degree of development of each specimen. Other sections 
were subjected to an indirect immunocytochemical method using a monoclonal 
antibody specific to proliferating cellular nuclear antigen (PCNA, Sigma) at the optimal 
dilution of 1:1000 as previously described [28]. The specificity of the reactions was 
determined by omitting the first antiserum. Slides were examined with an Axiolab 
(Zeiss) light microscope.  
2.5. Calculations and statistics 
All data are presented as mean ± standard error of the mean (SEM). The 
significance level (P) was fixed at 0.05. In order to determine differences between the 
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control and T, FIN, or T+FIN fish groups, respectively, and between T (or FIN) and 
T+FIN fish groups, Student’s t tests were performed. In addition, Pearson correlation 
tests were applied to test correlations among steroid levels and between steroid and 
mRNA expression levels for each experimental condition. Statistical analyses were 
conducted using SPSS 12.0 (SPSS, Chicago, IL, USA).  
PCNA immunostaining was calculated as the mean value ± SEM of the stained 
area/total area of 16 randomly distributed optical areas at X 200 magnification. The 
stained areas were measured by image analysis using a Nikon eclipse E600 light 
microscope, an Olympus SC30 digital camera (Olympus soft imaging solutions 
GMBH), and ImageJ software [29]. Proliferation rates in treated groups were expressed 
as fold change of control values and analyzed by the t-Student`s test (P ≤ 0.05).  
3. Results 
3.1. T implants transiently alter testosterone-derived steroid serum levels and 
transcript levels of the enzymes involved in their production 
Fifteen days after T treatment, increases in the T (Fig. 2A), 11KT (Fig. 2B) and 
E2 (Fig. 2D) and a decrease in the DHT (Fig. 2C) serum levels were recorded  
compared with the serum levels of the control fish, while 21 days after T treatment, only 
a decrease in the T serum levels was observed (Fig. 2A). In control fish, T serum levels 
positively correlated with the levels of 11KT (Fig. 2E) and E2 (Fig. 2F) and negatively 
correlated with those of DHT (Fig. 2G), while DHT serum levels negatively correlated 
with E2 serum levels (Fig. 2H). However, these correlations were not observed in T 
treated fish (data not shown). 
Then, in the gonad, we analysed how the T implants modified the transcript 
levels of the enzyme involved in the first reaction of cholesterol transformation into 
steroids (cyp11a1) and of the enzymes involved in T transformation into 11KT 
(cyp11b1 and hsd11b), into DHT (srd5a) or E2 (cyp19a1a) (Fig. 3). Fifteen days after T 
injection, the cyp11b1 (Fig. 3A) and hsd11b (Fig. 3B) mRNA levels were seen to have 
increased, while the srd5a transcript levels had fallen (Fig. 3C) compared with those of 
the control fish. A decrease in the transcript levels of cyp11b1 (Fig. 3A) and hsd11b 
(Fig. 3B) was also observed 21days after T treatment. In contrast, no differences were 
observed in the transcript levels of cyp11a1 or cyp19a1a between control and T-
implanted fish (data not shown). 
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 Furthermore, in control fish, the hsd11b transcript levels positively correlated 
with T serum levels (Fig. 3D), while cyp11a1 transcript levels negatively correlated 
with 11KT serum levels (Fig. 3E). However, in T-treated fish no such correlations were 
observed (data not shown).  
3.2. Finasteride affects sex steroid serum levels and transcript levels of the enzymes 
involved in their production  
Seven days after FIN injection, an increase was observed in T (Fig 4A), 11KT 
(Fig. 4B) and E2 (Fig. 4D) and a decrease in the DHT (Fig. 4C) serum levels compared 
to those of control fish. Moreover, in FIN treated fish, T serum levels positively 
correlated with those of 11KT (Fig. 4E) and E2 (Fig. 4F) and negatively correlated with 
DHT serum levels (Fig. 4G).  
In T+FIN treated fish a decrease in T (Fig. 4A), DHT (Fig. 4C) and E2 (Fig. 4D) 
serum levels at day 7 and an increase of T, at days 15 and 21, and of DHT, at day 21 
were observed compared to the serum levels of T treated fish. However, compared to 
the levels measured in control fish, T serum levels had increased at days 7 and 15, and 
11KT serum levels at day 7, while DHT serum levels had decreased at day 7 and 
increased at day 21 (Fig. 4A,B,C) and serum levels of E2 were not affected (Fig. 4D). 
Moreover at day 21 the serum levels of DHT were higher in T+FIN than in FIN fish 
(Fig. 4C). However, 11KT serum levels were not modified at any time in the T+FIN 
treated fish compared to T treated fish (Fig. 4B). 
Regarding the transcript levels of the genes coding for steroidogenic enzymes, 
cyp11b1 at day 7 (Fig. 5A) and of cyp19a1a at day 15 (Fig. 5C) were up-regulated after 
FIN injection compared to control fish, while those of hsd11b were down-regulated at 
day 7 in T+FIN treated fish compared to the T treated fish (Fig. 5B). However, neither 
FIN nor FIN+T treatments modified the transcript levels of cyp11a1 and srd5a (data not 
shown).  
In FIN treated fish, no correlations were observed between the serum levels of 
sex steroids and the levels of mRNA coding for the enzymes involved in 
steroidogenesis (data not shown). However, in T+FIN treated fish, there was a positive 
correlation between T serum levels and the levels of mRNA coding for cyp11a1 (Fig. 
5D), hsd11b (Fig. 5E) and srd5 (Fig. 5F).  
3.3. Testosterone and finasteride modify the testicular proliferation rates  
In the testis of control fish, which were at the resting stage, proliferative Sertoli 
cells, spermatogonia stem cells and a few cysts of primary spermatogonia were 
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observed using anti-PCNA serum (Fig. 6B). Implants of T did not produce any effect on 
the proliferative rate of the testes compared to that seen in control fish (Fig. 6A). 
However, FIN caused an increase in the proliferative rate of the testis compared with 
the control fish, the magnitude of which depended on the previous treatment (vehicle 
alone or vehicle plus T). Thus, in FIN treated fish, an increase in the proliferation rate 
was observed after 7 days, which decreased as the experiment progressed, while in 
T+FIN treated fish the proliferation rate increased gradually from day 15 after FIN 
injection until the end of the experiment (Fig. 6A).  
Interestingly T, FIN or T+FIN treatments affected the cell type that proliferated 
in the testis differently (Fig. 6). Compared to the testis of control fish, T-implants 
enhanced Sertoli cells but not spermatogonia proliferation (Fig. 6B, C), while FIN 
injection promoted an increase in the number of all proliferative cell types (Fig. 6D) at 
all sampling times. However, the testes of T+FIN treated fish showed a similar aspect to 
those of control fish 7 days after FIN injection, but displayed a progressive increase in 
the number of proliferative spermatogonia and cysts of spermatogonia, and also 
contained cysts of spermatocytes 21 days after FIN injection (Fig. 6E-G).  
4. Discussion 
In teleosts, as in mammals, the balance that exists between androgens and estrogens 
is essential for the reproductive process [30,31], T being the source of other steroids [1–
3]. Thus, E2 is derived from T through local aromatase activity in several tissues, 
including the testis [3,10,27], and the dominant androgen in male fish, 11KT, is 
synthesized from T by the sequential action of 11β-hydroxylase and 11β-hydroxysteroid 
dehydrogenase [1]. In recent years, there has been growing evidence that teleost fish 
produce DHT, the most potent androgen among other vertebrate groups [4], from T 
through 5α-reductase activity [1,2], although its exact role is still unclear. DHT has 
androgenic effects and seems to be involved in regulating spermatogenesis in a number 
of teleost species, as illustrated when fish are exposed to this compound [2,32]. In 
addition, it has recently been demonstrated that DHT serum levels positively correlate 
with T serum levels in pubertal European sea bass males [33]. To increase our 
understanding of the role of DHT in the reproductive physiology of hermaphrodite male 
fish, FIN was used to inhibit the 5α-reductase activity needed to transform T into DHT. 
Since the synthesis of 11KT, DHT and E2 depends on the availability of their precursor, 
T [1,24], changes in the serum levels of these sex steroids were expected. Indeed, the 
increased serum levels of T observed 15 days after T implantation were accompanied by 
11  
an increase in the levels of 11KT and E2. However, serum levels of DHT had decreased 
by this time, which is consistent with the decrease in the gene expression levels of 
srd5a, which codes for the 5α-reductase, and with the negative correlation between T 
and DHT levels found in control fish. Interestingly, control levels of T-derived steroids 
in serum recovered before T serum levels were normalized after T-implants. The rapid 
up- or down regulation of transcripts that code for the enzymes needed to produce 11KT 
(cyp11b1 and hsd11b) coincided with the respective increase or decrease in T serum 
levels. These data suggest that T serum levels regulate the kinetics of T transformation 
into 11KT, as further supported by the positive correlation between the T serum levels 
and hsd11b mRNA levels found in control fish. However, the transcript levels of 
cyp11a1 in the first and hormonally regulated step of steroid synthesis [34] were not 
affected by exogenous T, reflecting the findings of previous studies [24]. Furthermore, 
the high serum levels of 11KT promoted by exogenous T could contribute to the 
restoration of T control levels, since a negative correlation was found between serum 
levels of 11KT and cyp11a1 mRNA levels in control fish.  
FIN administration inhibited 5α-reductase activity, as shown in the sharp decrease in 
DHT serum levels 7 days after its application. In addition, although the pharmacology 
potency of T and FIN might be different and some of the FIN actions might be masked 
by high levels of T, the dose of FIN used in this study was able to inhibit the 5α-
reductase activity also in T-implanted fish. Interestingly, the inhibition of 5α-reductase 
activity had an effect similar to that caused by T treatment - an increase in T, 11KT and 
E2 serum levels - which could compensate the failing conversion of T into DHT in 
control fish. By contrast, in T-implanted fish which exhibited increased serum levels of 
these steroids, FIN did not affect 11KT while induced a decrease in E2 serum levels, 
possibly to avoid excessive levels that could harm the fish physiology. Serum levels of 
all steroids were restored at the end of the experiment in FIN treated fish; whilst only 
serum levels of 11KT and E2 were recovered in T+FIN treated fish at this time.  
DHT seems to regulate E2 levels, since inhibition of its synthesis in FIN treated fish 
up-regulated cyp19a1a expression and increased E2 serum levels, as occurs in 
amphibians [19,35]. E2 has been seen to mediate spermatogonia renewal in fish [36,37], 
which could explain the initial increase in proliferative spermatogonia in FIN treated 
fish, as they showed a considerable increase in E2 serum levels compared to the other 
experimental groups. However spermatogenesis did not progress in FIN treated fish, 
possibly because the subsequent restoration of control levels of all the steroids studied. 
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Interestingly, the proliferative rates and cell types observed in the testis of T+FIN 
treated fish were consistent with the onset of spermatogenesis 15 days after FIN 
injection, when cysts of spermatogonia increased in size and numbers, and with the 
progression of this process, as shown by the appearance of spermatocyte cysts 21 days 
after FIN injection. Of note is the fact that these fish showed higher DHT levels than 
those of the other experimental groups. These data suggests that DHT serum levels are 
not involved in triggering the mitotic or spermatogonial phase of spermatogenesis, as 
already seen in catfish [38] but in the passage from the mitotic phase to the meiotic 
phase of spermatogenesis when primary spermatocytes are produced. 
In conclusion our data show that T serum levels regulate DHT serum levels by 
down-regulating the transcript levels of srd5a, which codes for the enzyme responsible 
for its synthesis. Furthermore, the inhibition of T transformation into DHT revealed that 
DHT might have a role in the passage from the mitotic to the meiotic phase of 
spermatogenesis and be involved in the regulation of E2 serum levels in gilthead 
seabream males.  
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7. Figure legends 
Figure 1. Schema of the experimental design. bm, body mass; DMSO, 
dimethylsulfoxide; FIN, finasteride; PBS, phosphate buffer saline; T, testosterone. 
Figure 2. Sex steroid serum levels and significant correlations after T administration. 
(A-D) The serum levels of T (A), 11KT (B), DHT (C) and E2 (D) in control and T-
implanted gilthead seabream fish at 15, 21 and 28 days after T-implant injection. Data 
were obtained from 4 fish/group and represent the means ± S.E.M. of duplicate samples. 
Asterisks indicate a significant difference between groups accordingly to a t-student test 
(P ≤ 0.05). (E-H) Significant correlations between T and 11KT (E), E2 (F) or DHT (G) 
and between DHT and E2 (H) serum levels were observed in the control group. The 
Pearson rank number is indicated. Asterisks indicate a significant correlation (P ≤ 0.05). 
T, testosterone; 11KT, 11-ketotestosterone; DHT, 5α-dihydrotestosterone; E2, 17β-
estradiol. 
Figure 3. Transcript levels of some relevant steroidogenic enzyme coding genes and 
significant correlations with sex steroid serum levels after T administration. (A-C) 
Transcript levels of cyp11b1 (A), hsd11b (B) and srd5a (C) in the gonad of control and 
T-implanted gilthead seabream fish at 15, 21 and 28 days post-T-implant injection. All 
the mRNA levels were studied by real-time RT-PCR. Data represent means ± S.E.M. 
for 4 fish/group. Asterisks indicate a significant difference between groups accordingly 
to a t-student test (P ≤ 0.05). (D-E) Significant correlations between T and hsd11b (D) 
and between 11KT and cyp11a1 (E) were observed in the control group. The Pearson 
rank number is indicated. Asterisks indicate a significant correlation (P ≤ 0.05). T, 
testosterone; 11KT, 11-ketotestosterone. 
Figure 4. Sex steroid serum levels and significant correlations after FIN 
administration. (A-D) Serum levels of T (A), 11KT (B), DHT (C) and E2 (D) in control, 
finasteride (FIN), T or T+FIN treated gilthead seabream fish 7, 15 and 21 days after 
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FIN injection. Data were obtained from 4 fish/group and represent the means ± S.E.M. 
of duplicate samples. Asterisks denote statistically differences between groups 
accordingly to a t-student test (P ≤ 0.05). (E-G) Significant correlations between T and 
11KT (E), DHT (F) or E2 (G) serum levels observed in the FIN treated group. The 
Pearson rank number is indicated. Asterisks indicate a significant correlation (P ≤ 0.05). 
T, testosterone; 11KT, 11-ketotestosterone; DHT, 5α-dihydrotestosterone; E2, 17β-
estradiol. 
Figure 5. Transcript levels of relevant steroidogenic enzyme coding genes and 
significant correlations with sex steroid serum levels after FIN administration. (A-C) 
Transcript levels of cyp11b1 (A), hsd11b (B) and cyp19a1a (C) in the gonad of control, 
finasteride (FIN), testosterone (T) or T+FIN treated gilthead seabream fish 7, 15 and 21 
days after FIN injection. The mRNA levels of all genes were studied by real-time RT-
PCR. Data represent means ± S.E.M. from 4 fish/group. Asterisks denote statistically 
differences between groups accordingly to a t-student test (P ≤ 0.05). (D-F) Significant 
correlations between T serum levels and transcript levels of cyp11a1, hsd11b or srd5a 
were observed in the T+FIN treated group. The Pearson rank number is indicated. 
Asterisks indicate a significant correlation (*P≤0.05, **P≤0.01, ***P≤0.001).  
 
Figure 6. Testicular proliferative activity after T and/or FIN administration. (A) 
Proliferative rate expressed as fold change of control values and measured as the mean 
of the staining area with anti-proliferative cell nuclear antigen (anti-PCNA) per optical 
area at 7, 15 and 21 days post-finasteride (FIN) administration Asterisks denote 
statistically differences between groups accordingly to a t-student test (P ≤ 0.05). (B-G) 
Paraffin embedded section of control (B), testosterone (T) (C), FIN (D) and T+FIN (E-
G) treated fish staining with anti-PCNA serum and counterstained with hematoxylin. 
Scale bar=15 µm. Asterisk denote proliferative primary spermatogonia, black arrows 
denote proliferative Sertoli cells, SG denote cyst of proliferative spermatogonia and SC 
denote cysts of proliferative spermatocytes.   
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Table 1: Gene accession numbers and primer sequences used for gene expression 
analysis. 
Gene Accession number Name Sequence (5’-3’) Use 
Firstly used 
reference 
cyp11a1 FM159974.1 
F CGCTGCTGTGGACATTGTAT 
Real time PCR 
(Sánchez-
Hernández et 
al., 2013) 
R CATCATGTCTCCCTGGCTTT 
cyp11b1 FP332145   
F GCTATCTTTGGACCCCATCA 
Real time PCR 
R CTTGACTGTGCCTTTCAGCA 
hsd11b AM973598 
F AGACATGGGCAACGAGTCAG 
Real time PCR 
R TCCACATCTCCCTCCCACAT 
srd5a AM958800 
F TGCACTTTCGTGACTCTGCT 
Real time PCR 
R TTTCGCACAAGACGTCCAGA 
cyp19a1a AF399824 
F2 CAATGGAGAGGAAACCCTCA 
Real time PCR 
R2 ATGCAGCTGAGTCCCTGTCT 
rps18 AM490061 
F AGGGTGTTGGCAGACGTTAC 
Real time PCR 
(Chaves-Pozo 
et al., 2008) R CTTCTGCCTGTTGAGGAACC 
 
 
 
Highlights 
1. T serum levels regulate DHT serum levels by down-regulating the transcript levels 
of srd5a.  
2. DHT triggers the onset of the meiotic phase of spermatogenesis. 3. DHT is involved in the regulation of E2 serum levels.  
